Clinical trial
Characterization of the Initial Psoriatic Skin Transcriptionnl Profile Associated to a Response to Adalimumab Therapy
NCT03389984 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of the Initial Psoriatic Skin Transcriptionnl Profile Associated to a Response to Adalimumab Therapy
- Lead sponsor
- Poitiers University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 14, 2017
- Completion date
- June 18, 2020
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
psoriasis vulgaris